Skip to main content
KBS_Icon_questionmark link-ico
Maughan Round room ;

'I'm proud to represent Taiwan working at the intersection of biotech and inclusion'

Enchia Tsai (MSc Psychology & Neuroscience of Mental Health, 2024) is the co-founder of Bened Biomedical, which provides psychobiotic supplements to improve the nervous system and support mental health. Based in Taiwan, Enchia is also the Global Winner of the Business & Innovation category in the 2025 Study UK Alumni Awards.

A young woman with dark hair, wearing a red jacket and a black top.
‘Stay grounded in science, collaborate across disciplines and never underestimate the power of empathy,’ says Enchia

What attracted you to study at King’s?

King’s has long been a global leader in neuroscience and mental health research. I was drawn to its academic reputation, interdisciplinary approach and the Institute of Psychiatry, Psychology & Neuroscience. The opportunity to learn from world-class experts while staying professionally active in Taiwan was also invaluable.

Why did you choose Psychology & Neuroscience of Mental Health?

I wanted to deepen my understanding of the biological and psychological mechanisms behind neurodiversity and mental health conditions. This knowledge strengthens my work in psychobiotics, helping bridge science with real-world impact.

A young woman with dark hair and wearing a black, coat, black trousers and a white top stands outside the ornate main entrance to Bush House on the Strand. She smiles and holds a cup of coffee in one hand.
‘I’ll always cherish quiet moments at Roots Café on the rooftop of Bush House, sipping coffee while overlooking the Thames,’ says Enchia

What’s your favourite memory of King’s?

Beyond the intellectual journey, I’ll always cherish quiet moments at Roots Café on the rooftop of Bush House, sipping coffee while overlooking the Thames and London skyline.

What’s the key lesson you learnt at King’s?

That scientific excellence and empathy are not mutually exclusive. The programme taught me to appreciate rigour while remaining sensitive to lived experience. This is an essential balance when innovating for neurodiverse communities.

You’re the co-founder of Bened Biomedical. Can you tell us about its genesis?

Bened was born out of our research on psychobiotics at Taiwan’s National Yang Ming University. We saw that specific probiotic strains had potential to support neurological conditions like autism and Parkinson’s. I co-founded the company to translate this emerging science into accessible solutions with measurable impact.

Can you tell us about the work of Bened Biomedical?

We develop clinically validated psychobiotics. These are probiotic strains with demonstrated neurological and mental health benefits.

Our flagship strain, PS128, is now used globally under the brands Neuralli™ and InSeed, and is available in more than 60 countries. We collaborate with researchers and clinicians worldwide to explore its applications in neurodevelopmental and neurodegenerative conditions such as Parkinson’s and autism.

You were also a Global Winner in this year’s Study UK Alumni Awards…

Yes. I was the Global Winner in the Business & Innovation category. It was a joyful surprise. I’ve always seen our work as a bridge between science and humanity, and being recognised on a global stage affirmed that vision.

As a woman and a mother, this honour came at a particularly challenging time in my parenting journey, offering not just encouragement but the strength to keep moving forward. I’m especially proud to represent Taiwan as a first-generation founder working at the intersection of biotech and inclusion.

A young woman with dark hair and wearing graduation robes stands next to a man with dark hair, glasses, a black t-shirt and tan trousers. In front of them is a buggy with a child inside. In the background is a banner that reads ‘King’s College London’.
‘As a woman and a mother, this honour offered not just encouragement but the strength to keep moving forward,’ says Enchia

Will this win help raise the profile of your work?

Winning such a prestigious and high-profile award has significantly raised the visibility of my work. Since the announcement, it has attracted widespread media coverage in Taiwan, helping more consumers and industry peers understand that our innovations have gained international recognition.

Globally, it has also opened doors to new commercial collaborations and press invitations, allowing us to expand the reach and impact of our psychobiotics.

You also serve on the board of the Taipei Women’s Rescue Foundation…

The Foundation supports survivors of domestic violence and digital sexual abuse, and advocates for gender justice in law and policy.

As a board member, I help guide strategic outreach and promote psychological recovery and empowerment, especially for women facing systemic trauma. Recently, we’ve been working to enhance national resilience planning, ensuring marginalised communities are not left behind in times of crisis.

What’s next for you?

Beyond navigating the daily chaos of raising a child while running a company, I’m currently leading preparation for Bened Biomedical’s Initial Public Offering to investors in 2026. This milestone will enable us to invest more deeply in research and innovation to support neurodiverse communities with tailored, science-based solutions.

We also hope to advance neurodiversity destigmatisation in Asia, so that every unique mind can be seen, respected and supported.

Finally, what advice would you give to King’s alumni aiming for careers in neuroscience?

I must admit I don’t have the most comprehensive insight into all neuroscience careers. But from my own corner of the industry, I’d say the future of neuroscience lies not only in data, but in understanding how it transforms lives.

I’d also advise anyone working in the area to stay grounded in science, collaborate across disciplines and never underestimate the power of empathy.

Learn more about Bened Biomedical

Latest news